GlassScriptPhysician profile
Daniel E Asemota
NPI 1033616578
$155,154.99
in general payments reported to CMS, 2019-2025
23 companies · $123K in 2025
The $123K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.78 · 2023: $1,211 · 2024: $31K · 2025: $123K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $136K · Food and Beverage: $15K · Travel and Lodging: $3,478 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $136,245.30 |
| Food and Beverage | $15,190.23 |
| Travel and Lodging | $3,477.59 |
| Education | $223.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $84,305.08 | 2024-2025 | General - Atherectomy, General - Therapies, Emerge Push |
| Abbott Laboratories | $46,434.88 | 2024-2025 | Xience V, Ultreon, Diamondback Coronary |
| Medtronic, INC. | $13,222.95 | 2023-2025 | Onyx Frontier, Symplicity G3, Ffrangio |
| Abiomed | $2,817.06 | 2024-2025 | Impella |
| Biotronik INC. | $2,179.56 | 2023-2025 | Acticor 7 Vr-T Dx, Pamira, Biomonitor |
| Shockwave Medical, INC | $1,544.19 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $1,179.60 | 2023-2025 | Farxiga, Wainua, Lokelma |
| Asahi Intecc USA, INC. | $520.86 | 2025 | Asahi Coronary Wires, Asahi Peripheral Vascular Wires |
| Heartflow, INC. | $470.82 | 2025 | |
| Amgen INC. | $413.08 | 2023-2025 | Repatha, Repatha |
| Philips North America LLC | $300.68 | 2025 | Ice 3d, Coronary Other, Igt Devices Undivided |
| Endologix LLC | $253.53 | 2025 | Torus Stent Graft System, Endocross Device |
| Acist Medical Systems, INC. | $253.16 | 2024 | |
| Recor Medical INC | $227.49 | 2025 | Paradise Ultrasound Renal Denervation System |
| Spectrawave, INC | $199.16 | 2025 | Hypervue Imaging System, Starlight Imaging Catheter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $158.41 | 2025 | Pascal |
| Penumbra, INC. | $153.51 | 2025 | Indigo System |
| Pfizer INC. | $151.87 | 2022-2024 | |
| Terumo Medical Corporation | $132.72 | 2024-2025 | Angio-Seal, Tr Band, Metacross Otw |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.41 | 2023-2024 | Jardiance |
| Cardiva Medical, INC. | $44.15 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Surmodics, INC. | $43.32 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Novartis Pharmaceuticals Corporation | $22.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Asemota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.